Skip to main content
Livermore
Livermore
ZHEN

Stephens Inc

SEC CIK
0000757657
Latest filing
Jul 29, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Stephens Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
4,954
Value
$387.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Stephens Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,954$387.8K<0.1%+397+8.7%AddedHolders
Q1 20264,557$294.5K<0.1%+495+12.2%AddedHolders
Q4 20254,062$273.4K<0.1%−95−2.3%ReducedHolders
Q3 20254,157$304.9K<0.1%−1,050−20.2%ReducedHolders
Q2 20255,207$270.9K<0.1%−244−4.5%ReducedHolders
Q1 20255,451$347.8K<0.1%−13−0.2%ReducedHolders
Q4 20245,464$261.2K<0.1%−1,377−20.1%ReducedHolders
Q3 20246,841$391.6K<0.1%−2,342−25.5%ReducedHolders
Q2 20249,183$480.8K<0.1%−36−0.4%ReducedHolders
Q1 20249,219$375.0K<0.1%+2,930+46.6%AddedHolders
Q4 20236,289$232.4K<0.1%+159+2.6%AddedHolders
Q3 20236,130$234.2K<0.1%+255+4.3%AddedHolders
Q2 20235,875$211.9K<0.1%+2,953+101.1%AddedHolders
Q1 20232,922$111.6K<0.1%+23+0.8%AddedHolders
Q4 20222,899$165.0K<0.1%00.0%UnchangedHolders
Q3 20222,899$115.0K<0.1%00.0%UnchangedHolders
Q2 20222,899$128.0K<0.1%00.0%UnchangedHolders
Q1 20222,899$116.0K<0.1%+369+14.6%AddedHolders
Q4 20212,530$102.0K<0.1%00.0%UnchangedHolders
Q3 20212,530$103.0K<0.1%00.0%UnchangedHolders
Q2 20212,530$115.0K<0.1%00.0%UnchangedHolders
Q1 20212,530$105.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.